Sign In
Buy NEO
$15.29
-0.590 (-3.72%)
At Close: Jul 31, 2026
NeoGenomics (NEO) Moves 6.3% Higher: Will This Strength Last?
04:56am, Thursday, 16'th Oct 2025
NeoGenomics (NEO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength
NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025
07:05am, Tuesday, 14'th Oct 2025
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will share at ESMO 2025 how its RaDaR ST MRD assay can support pharmaceutical partners across oncology research and clinical trials.
NeOnc Technologies: From Survival Mode To Expansion Mode
02:25pm, Thursday, 09'th Oct 2025
NeOnc Technologies Holdings is a micro-cap biotech focused on innovative brain cancer treatments, NEO100 and NEO212, both in early clinical trials. NTHI's financials are challenging, with no revenue,
Tenneco Unveils GLYCODUR® NEO, The PFAS-Free Bearing Material Advancing Sustainability
06:38am, Wednesday, 08'th Oct 2025
Engineered for high-performance in both dry and lubricated applications across automotive and industrial sectors Engineered for high-performance in both dry and lubricated applications across automoti
NEW YORK--(BUSINESS WIRE)-- #NEOHomeLoans--NEO Home Loans powered by Better, a mortgage lender combining elite loan advisors with industry-leading technology to redefine the home financing experience,
NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025
07:05am, Tuesday, 07'th Oct 2025
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will report its third quarter 2025 financial results prior to the open of the U.S. financial markets on Tuesday, Oct. 28, 2025.
NEO Battery Signs Multi-Year Offtake Agreement for Silicon Battery Materials with North American Drone & UAS Battery Company
08:00am, Thursday, 02'nd Oct 2025
TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (“NEO” or the “Company”) (T S X V : NBM) (OTC: NBMFF), a low-cost, silicon-enhanced battery developer that enables longer-
NEO Battery Closes Upsized Non-Brokered Private Placement Offering of $5.5 Million
08:30am, Monday, 29'th Sep 2025
TORONTO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (“NEO” or the “Company”) (T S X V : NBM) (OTC: NBMFF), a low-cost, silicon-enhanced battery developer that enables longer
TORONTO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (“NEO” or the “Company”) (T S X V : NBM) (OTC: NBMFF), a low-cost, silicon-enhanced battery developer that enables longer
TORONTO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (“NEO” or the “Company”) (T S X V : NBM) (OTC: NBMFF), a low-cost, silicon-enhanced battery developer that enables longer
NeoGenomics Stock In A Range-Bound Matrix, Weakness Likely Until 2026
07:58am, Wednesday, 17'th Sep 2025
NeoGenomics NEO is in Phase 18, the final stage of its Adhishthana Cycle on the weekly charts. After more than 850 days of consolidation, the stock shows little sign of breaking out.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO
10:00am, Saturday, 13'th Sep 2025
NEW YORK , Sept. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO).
NEO Battery Secures $4.5 Million Purchase Order for High-Performance Silicon Battery Solutions from Asian Drone Manufacturer
08:38am, Friday, 12'th Sep 2025
TORONTO, Sept. 12, 2025 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (“NEO” or the “Company”) (T S X V : NBM) (OTC: NBMFF), a low-cost, silicon-enhanced battery materials and components deve
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO
02:50pm, Wednesday, 10'th Sep 2025
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO). Such inves
CALABASAS, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company pion
